衰老与临床前阿尔茨海默病的昼夜静息-活动模式变化
这项横断面研究纳入205名认知正常社区志愿者,通过7-14天家庭活动记录仪、PiB淀粉样蛋白成像和脑脊液生物标志物评估昼夜节律与临床前AD病理的关联。结果显示,临床前淀粉样斑块病理与静息-活动节律碎片化独立相关,衰老也与昼夜节律功能障碍相关,尤其在男性中。
要点
- 临床前AD病理与静息-活动节律碎片化独立相关。
- 衰老与昼夜节律功能障碍相关,且独立于临床前AD病理,男性更明显。
- 昼夜节律异常可能作为临床前AD的生物标志物或参与早期发病机制。
核心结论
- 临床前AD与静息-活动节律碎片化相关,独立于年龄和性别。
- 衰老也与昼夜节律功能障碍相关,独立于临床前AD病理,尤其在男性中。
- 临床前阶段的昼夜节律异常提示其可能参与早期发病机制或作为生物标志物。
研究设计与样本
- 横断面研究,纳入认知正常社区志愿者205人,最终分析189人。
- 参与者来自华盛顿大学圣路易斯Knight阿尔茨海默病研究中心。
- 2010至2012年间进行7至14天家庭活动记录仪监测,并收集临床评估、PiB淀粉样蛋白成像和脑脊液生物标志物数据。
主要发现
- 年龄较大(β=.247;P=.003)和男性(β=.170;P=.04)在无淀粉样病理时与日间变异度增加相关。
- PiB阳性者平均(SD)值为0.875(0.178),PiB阴性者为0.804(0.187),P=.05,与日间变异度增加相关。
- 脑脊液磷酸化tau与淀粉样β42比值升高(β=.231;P=.008)与日间变异度增加相关。
临床怎么用
- 在认知正常老年人中,可关注静息-活动节律碎片化作为临床前AD的潜在生物标志物。
- 对男性衰老相关的昼夜节律功能障碍需独立于AD病理进行评估。
局限性
- 横断面设计无法确定因果关系。
- 样本为社区志愿者,可能存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Circadian rhythm disturbances occur in symptomatic Alzheimer disease (AD) and have been hypothesized to contribute to disease pathogenesis. However, it is unknown whether circadian changes occur during the presymptomatic phase of the disease. OBJECTIVE: To examine the associations between circadian function, aging, and preclinical AD pathology in cognitively normal adults. DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional study was conducted using community volunteers from the Knight Alzheimer's Disease Research Center at Washington University in St Louis. Cognitively normal participants (n = 205) underwent 7 to 14 days of actigraphy in their home environment between 2010 and 2012, in addition to clinical assessment, amyloid imaging with Pittsburgh Compound B (PiB), and cerebrospinal fluid biomarker collection. Data collected from 3 years before to 6 months after actigraphy were included. Sixteen participants were excluded owing to incomplete data collection. MAIN OUTCOMES AND MEASURES: Circadian rhythm analysis was performed on actigraphy data using 3 methods: cosinor, nonparametric, and empirical mode decomposition. Preclinical AD was assessed by longitudinal clinical assessment, amyloid imaging with PiB, and cerebrospinal fluid biomarker collection. RESULTS: Data from 189 participants were included in the analyses. The mean (SD) age was 66.6 (8.3) years, and 121 participants (64%) were women. Older age (β = .247; P = .003) and male sex (β = .170; P = .04), in the absence of amyloid pathology, were associated with a significant increase in intradaily variability, a nonparametric measure of rest-activity rhythm fragmentation, as well as decreased amplitude by several measures. After correction for age and sex, the presence of preclinical amyloid plaque pathology, assessed by positive PiB imaging (mean [SD], 0.804 [0.187] for PiB negative vs 0.875 [0.178] for PiB positive; P = .05) or increasing cerebrospinal fluid phosphorylated-tau to amyloid β 42 ratio (β = .231; P = .008), was associated with increased intradaily variability, indicating rest-activity rhythm fragmentation. CONCLUSIONS AND RELEVANCE: Preclinical AD is associated with rest-activity rhythm fragmentation, independent of age or sex. Aging was also associated with circadian dysfunction independently of preclinical AD pathology, particularly in men. The presence of circadian rhythm abnormalities in the preclinical phase of AD suggests that circadian dysfunction could contribute to early disease pathogenesis or serve as a biomarker of preclinical disease.
引用
- Musiek ES, Bhimasani M, Zangrilli MA, et al. Circadian Rest-Activity Pattern Changes in Aging and Preclinical Alzheimer Disease. JAMA Neurol. 2018. PMID: 29379963. doi:10.1001/jamaneurol.2017.4719
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。